AGM/EGM19 Aug 2026, 05:40 pm
Sandu Pharmaceuticals Announces 41st AGM on Sep 11, 2026
AI Summary
Sandu Pharmaceuticals Ltd has announced its 41st Annual General Meeting (AGM) to be held on Friday, September 11, 2026, at 4:30 PM IST. The meeting will be conducted through Video Conferencing or other audio-visual means. Key agenda items include the adoption of the audited standalone financial statements for the financial year ended March 31, 2026, reappointment of Smt Jayshree Sandu as a Director, declaration of a dividend of ₹1.00 per equity share (10%), and appointment of M/s. Dave & Dave as Statutory Auditors for a term of five years. The company has also initiated the process of sending the AGM notice electronically to shareholders and has uploaded the Annual Report 2025-26 on its website.
Key Highlights
- AGM scheduled for September 11, 2026, via VC/OAVM.
- Dividend of ₹1.00 per share (10%) proposed for FY26.
- M/s. Dave & Dave appointed as Statutory Auditors for 5 years.
- Audited financial statements for FY26 to be adopted.
- Smt Jayshree Sandu to be reappointed as Director.
Price Impact
More from SANDUPHQ